Drug manufacturers are under increasing pressure to ensure that their drug development research yields reliable results. They are constantly being forced to conduct more cost-effective and targeted clinical trials. The success of recruitment plays a key role in this. Hundreds of thousands of new patients are needed in the clinical trial market worldwide every year, but searching for them is like “looking for a needle in a haystack,” as they need to be found and selected from more than 1 billion people.

Human clinical drug development is a long and costly process from molecular design to the day-to-day clinical use of a particular human drug. The participation of an adequate number of patients in the research process is essential for the success of the project. With the solutions currently in use, the actors cannot effectively assist in the selection process, patient recruitment involves a lot of extra work.

IQ Labor provides a solution to these problems with a method that helps the recruitment process nationwide and effectively. For those eligible to do so, IQ Labor provides direct access to select the right patient, speeding up and simplifying the search process while all participants benefit from joining the system.